New treatments for rare bone diseases: hypophosphatemic rickets/osteomalacia.

Julia Vieira Oberger Marques, Carolina Aguiar Moreira, Victoria Zeghbi Cochenski Borba

Open access · diamondAbstract readReview

In one paragraph

Review in Archives of endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

1.2field-weighted citation impact, top 23% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

The Intricacies of Renal Phosphate Reabsorption-An Overview.International journal of molecular sciences · 2024
Review
De Novo Large Deletions in theDiagnostics (Basel, Switzerland) · 2023
Article
A Case of Tumor-Induced Osteomalacia Detected by Venous Sampling.International medical case reports journal · 2023
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Julia Vieira Oberger MarquesResidência em Endocrinologia no Serviço de Endocrinologia do Hospital de Clínicas da Universidade Federal do Paraná (SEMPR/UFPR); Certificação Board em Endocrinologia e Metabolismo pela Sociedade Brasileira de Endocrinologia e Metabologia (SBEM); Medicina Interna pela UFPR, Curitiba, PR, Brasil.

Carolina Aguiar MoreiraDepartamento de Clínica Médica da Universidade Federal do Paraná (UFPR); Centro Acadêmico de Pesquisa do Instituto Pró-Renal (PRO), Curitiba, PR, Brasil.

Victoria Zeghbi Cochenski BorbaDepartamento de Clínica Médica da Universidade Federal do Paraná (UFPR); Unidade de Ossos do Serviço de Endocrinologia do Hospital de Clínicas da UFPR (SEMPR/UFPR), Curitiba, PR, Brasil; Unidade de Ossos da University of Arkansas for Medical Sciences (UAMS), Arkansas, EUA, vzcborba@gmail.com.

Agostinho Neto University · AOHospital de Clínicas Universidade Federal do Paraná · BRUniversidade Federal do Paraná · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphorus is one of the most abundant minerals in the human body; it is required to maintain bone integrity and mineralization, in addition to other biological processes. Phosphorus is regulated by parathyroid hormone, 1,25-dihydroxyvitamin D

Indexed as

Familial Hypophosphatemic RicketsOsteomalaciaAdultChildFibroblast Growth FactorsHumansParaneoplastic SyndromesPhosphatesPhosphorusFibroblast Growth FactorsPhosphatesPhosphorusburosumabFGF-23Hypophosphatemiaosteomalaciarickets

Identifiers

PMID36382755

DOI10.20945/2359-3997000000555

PMCPMC10118827

OpenAlexW4309362584

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.